A popular diabetes drug just got a major new approval — and it could be a game-changer for millions of Americans at risk for kidney failure.

Ozempic's expanded approval in the U.S. could transform how doctors treat patients with the condition, which involves a gradual loss of kidney function.

Research links weight loss medications like Ozempic and Zepbound to certain serious eye conditions.

Ozempic reduced the risk of severe kidney outcomes — including kidney failure, reduction in kidney function, or death from kidney or heart causes — by 24% in diabetic patients with chronic ...

In an important regulatory win for Denmark’s Novo Nordisk, the US Food and Drug Administration (FDA) yesterday approved Ozempic (semaglutide) to reduce the risk of kidney disease worsening, kidney ...

Ozempic is already approved to treat Type ... “The more we can delay the decline in kidney function, the better,” said Dr. Melanie Hoenig, a nephrologist at Beth Israel Deaconess Medical ...

The Food and Drug Administration approved Ozempic to be used to lessen the risk of kidney disease from getting worse, ...